Last reviewed · How we verify

NCT06874829: PAPE-BFR-EMS

Post-Activation Performance Enhancement in Single and Multi-Joint Exercises With BFR and EMS in Male Volleyball Players

Active, enrolled NA Last updated 13 March 2025
What this trial tests

NA trial testing Electrical Muscle Stimulation in Volleyball Players in 15 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
10 February 2025
Primary endpoint
9 August 2025
29 October 2025

Quick facts

Lead sponsorKarabuk University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment15
Start date10 February 2025
Primary completion9 August 2025
Estimated completion29 October 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Karabuk University

Who can join

Adults 18 to 30, male only, with Volleyball Players or Post Activation Potentiation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators used a randomized controlled crossover design to compare the effect of blood flow restriction (BFR) and electrical muscle stimulation (EMS) protocols on post-activation performance enhancement (PAPE) in multi-joint versus single-joint exercises. Participants took part in six test sessions 72 hours apart. In the BFR group, 50% of the arterial occlusion pressure (AOP) was used. In the EMS group, a 75 Hz current was applied. In the Low Resistance exercise group, only exercise was performed without any condition. Bench press (multi-joint) and triceps push-down (single-joint) exercises were used in the conditions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Electrical Muscle Stimulation

Trials testing the same drug.

Other Karabuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06874829.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing